The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Parkinson’s Disease Therapeutics Pipeline Program, 2025Novel Small Molecules to Slow PD Progression in a Genetically Defined Subset of People with PD
Study Rationale: Currently, drug discovery efforts for neurodegeneration are almost exclusively focused on disease risk, not the progression biology that afflicts patients when they present with...
-
Research Grant, 2025Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD.
Study Rationale: Sometimes, a "typo" in a gene called LRRK2 increases the risk of Parkinson's disease (PD), leading to a distinct PD version called LRRK2-PD. While people with LRRK2-PD maintain good...
-
Research Grant, 2025Validation of the Usability of Patient-specific Midbrain Organoids for LRRK2 Drug Discovery in Parkinson’s Disease
Study Rationale: Parkinson’s disease (PD) is a progressive brain disorder characterized by the loss of dopamine-producing neurons. OrganoTherapeutics has developed advanced midbrain organoid models...
-
Accelerating Biological Understanding and Therapeutic Translation For Parkinson’s Disease- Biology, 2025(SUPPLEMENT) Validation of LRRK2 Modifiers as Potential PD Therapeutic Targets
-
Research Grant, 2025Applying the Neuronal Alpha-synuclein Disease Integrated Staging System in Multiple System Atrophy
Study Rationale: The neuropathological hallmark feature of Parkinson’s disease (PD) is the accumulation of a misfolded protein called alpha-synuclein in neurons, which qualifies PD as a neuronal...
-
Research Grant, 2025(SUPPLEMENT) Enhancing Brain Clearance Mechanisms to Limit Parkinson Disease Progression
Study Rationale: Recent evidence has shown that people with Parkinson’s disease have a buildup of toxic proteins in their brains, as a result of impaired waste clearance mechanisms. Linked to this...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.